Kidney and liver drug study stopped early
Disease control
Terminated
This study looked at whether vonafexor could help kidney function in people with mild to moderate chronic kidney disease and suspected MASH (a liver condition). Ten participants were enrolled, but the study was terminated early. The goal was to measure changes in kidney function …
Phase: PHASE2 • Sponsor: Enyo Pharma • Aim: Disease control
Last updated May 11, 2026 20:47 UTC